Clinical Trial Update: Therapeutic Efficacy of Oral L-Ornithine-L-Aspartate on Minimal Encephalopathy [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the efficacy of oral L-ornithine-L-aspartate for minimal hepatic encephalopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy
• Minimal Hepatic Encephalopathy

Drugs mentioned

• L-ornithine-L-aspartate (L-ornithine-L-aspartate)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Hepatic Encephalopathy | Phase 4 | Status: UNKNOWN